Kodiak Sciences Stock (NASDAQ:KOD)


ForecastOwnershipFinancialsChartTranscripts

Previous Close

$3.84

52W Range

$1.59 - $7.77

50D Avg

$2.88

200D Avg

$3.61

Market Cap

$205.20M

Avg Vol (3M)

$195.32K

Beta

2.34

Div Yield

-

KOD Company Profile


Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is KSI-301, an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as well as for the treatment of diabetic macular edema, naïve macular edema due to retinal vein occlusion, and non-proliferative diabetic retinopathy. The company's preclinical stage product candidate includes KSI-501, a bispecific conjugate to treat retinal diseases with an inflammatory component; and KSI-601, a triplet inhibitor for the treatment of dry AMD. The company was formerly known as Oligasis, LLC and changed its name to Kodiak Sciences Inc. in September 2015. Kodiak Sciences Inc. was incorporated in 2009 and is based in Palo Alto, California.

Show More

Industry

Biotechnology

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

111

IPO Date

Oct 04, 2018

Website

KOD Performance


KOD Financial Summary


Dec 23Dec 22Dec 21
Revenue---
Operating Income$-277.32M$-341.38M$-267.05M
Net Income$-260.49M$339.74B$-258.09M
EBITDA$-251.37M$-333.81M$-266.97M
Basic EPS$-4.97$6.50K$-4.98
Diluted EPS$-4.97$6.50K$-4.98

Fiscal year ends in Dec 23 | Currency in USD

Latest Earnings Call Transcripts


Q4 23Mar 28, 24 | 8:57 PM
Q1 20May 13, 20 | 1:51 AM
Q3 19Nov 13, 19 | 8:39 PM

Peer Comparison


TickerCompany
CKPTCheckpoint Therapeutics, Inc.
AKROAkero Therapeutics, Inc.
GOSSGossamer Bio, Inc.
RVPHReviva Pharmaceuticals Holdings, Inc.
BMEABiomea Fusion, Inc.
STOKStoke Therapeutics, Inc.
SRPTSarepta Therapeutics, Inc.
CTMXCytomX Therapeutics, Inc.
SPROSpero Therapeutics, Inc.
RNAZTransCode Therapeutics, Inc.
ASMBAssembly Biosciences, Inc.
EYENEyenovia, Inc.
MBIOMustang Bio, Inc.
CGTXCognition Therapeutics, Inc.
NLTXNeurogene Inc.
FIXXQ32 Bio Inc.
MDGLMadrigal Pharmaceuticals, Inc.
TILInstil Bio, Inc.